University of Rochester Medical Center, Rochester, New York, USA
University of Rochester Medical Center, Rochester, New York, USA.
BMJ Open. 2022 Oct 3;12(10):e061332. doi: 10.1136/bmjopen-2022-061332.
Pulmonary disease is a significant cause of morbidity and mortality in adults and children, but most of the world lacks diagnostic imaging for its assessment. Lung ultrasound is a portable, low-cost, and highly accurate imaging modality for assessment of pulmonary pathology including pneumonia, but its deployment is limited secondary to a lack of trained sonographers. In this study, we piloted a low-cost lung teleultrasound system in rural Peru during the COVID-19 pandemic using lung ultrasound volume sweep imaging (VSI) that can be operated by an individual without prior ultrasound training circumventing many obstacles to ultrasound deployment.
Pilot study.
Study activities took place in five health centres in rural Peru.
There were 213 participants presenting to rural health clinics.
Individuals without prior ultrasound experience in rural Peru underwent brief training on how to use the teleultrasound system and perform lung ultrasound VSI. Subsequently, patients attending clinic were scanned by these previously ultrasound-naïve operators with the teleultrasound system.
Radiologists examined the ultrasound imaging to assess its diagnostic value and identify any pathology. A random subset of 20% of the scans were analysed for inter-reader reliability.
Lung VSI teleultrasound examinations underwent detailed analysis by two cardiothoracic attending radiologists. Of the examinations, 202 were rated of diagnostic image quality (94.8%, 95% CI 90.9% to 97.4%). There was 91% agreement between radiologists on lung ultrasound interpretation among a 20% sample of all examinations (κ=0.76, 95% CI 0.53 to 0.98). Radiologists were able to identify sequelae of COVID-19 with the predominant finding being B-lines.
Lung VSI teleultrasound performed by individuals without prior training allowed diagnostic imaging of the lungs and identification of sequelae of COVID-19 infection. Deployment of lung VSI teleultrasound holds potential as a low-cost means to improve access to imaging around the world.
肺部疾病是成人和儿童发病率和死亡率的重要原因,但世界上大多数地区缺乏评估肺部疾病的诊断成像技术。肺部超声是一种便携式、低成本且高度准确的成像方式,可用于评估肺部病理学,包括肺炎,但由于缺乏受过培训的超声技师,其应用受到限制。在这项研究中,我们在 COVID-19 大流行期间在秘鲁农村试用了一种低成本的远程肺部超声系统,该系统使用肺部超声容积扫描成像(VSI),即使是没有先前超声培训的人员也可以操作,这绕过了许多超声部署的障碍。
试点研究。
研究活动在秘鲁农村的五家医疗中心进行。
共有 213 名参与者到农村诊所就诊。
秘鲁农村没有先前超声经验的人员接受了如何使用远程超声系统和进行肺部超声 VSI 的简短培训。随后,这些以前没有接受过超声培训的操作人员使用远程超声系统对前来就诊的患者进行扫描。
放射科医生检查超声图像以评估其诊断价值并识别任何病理学。随机抽取 20%的扫描进行读者间可靠性分析。
两名心胸放射科主治医生对肺部 VSI 远程超声检查进行了详细分析。在所有检查中,有 202 次被评为具有诊断图像质量(94.8%,95%CI 90.9%至 97.4%)。在所有检查的 20%样本中,放射科医生对肺部超声检查的解释有 91%的一致性(κ=0.76,95%CI 0.53 至 0.98)。放射科医生能够识别 COVID-19 的后遗症,主要发现是 B 线。
没有先前培训的人员进行的肺部 VSI 远程超声检查可对肺部进行诊断成像,并识别 COVID-19 感染的后遗症。肺部 VSI 远程超声的应用具有作为一种低成本手段来改善全球各地获得成像的潜力。